This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Thomas Rupp
Owner & Principal at Thomas Rupp Consulting AG
Speaker

Profile

Thomas Rupp has been a leader in oligonucleotide manufacturing since 1985, when he established Europe’s first oligonucleotide synthesis facility at the German Cancer Research Center. He has contributed to DNA synthesizer development at EMBL, cancer research at Loyola University, and therapeutic oligonucleotide production at Innovir GmbH and Noxxon Pharma AG. He later served as a Global Field Application Specialist at GE Healthcare and as a CMC expert at Girindus Ltd. In 2013, he founded Thomas Rupp Consulting UG, and he now leads Axolabs Berlin GmbH as Managing Director.

Agenda Sessions

  • Workshop Co-Moderators’ Welcome and Opening Remarks

    09:00
  • Process-related Impurities, Their Origin and How to Control Them

    11:00
  • Achieving Control in Oligo Manufacturing: Innovations, Strategies, and Technologies

    13:25